Biotx.ai Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.22M
Latest Deal Amount
  • Investors
  • 7

Biotx.ai General Information

Description

Developer of a drug development platform designed to identify significant patterns for the development of novel diagnostics and therapies. The company's platform provides an effective way to monitor individual responses to drug action and uses machine learning algorithms like artificial neural networks to stratify patients in clinical studies, enabling physicians to currently overcome unmet medical needs.

Contact Information

Website
www.biotx.ai
Formerly Known As
Beroceutica
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Primary Office
  • C/o TechCode
  • Jägeralle 16
  • 14469 Potsdam
  • Germany
+49 01512 0000000

Biotx.ai Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotx.ai Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC $2.22M 00.00 Completed Generating Revenue
6. Early Stage VC 01-Jan-2019 000.00 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2019 000.00 Completed Generating Revenue
4. Accelerator/Incubator 20-Mar-2018 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 21-Jul-2017 0000 0000 00000 Completed Startup
2. Grant 09-Jul-2015 Completed Startup
1. Angel (individual) Completed Startup
To view Biotx.ai’s complete valuation and funding history, request access »

Biotx.ai Patents

Biotx.ai Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3790994-A1 Method for predicting the risk of late-onset alzheimer's diseases Pending 07-May-2018 0000000000
US-20210230696-A1 Method for predicting the risk of late-onset alzheimer's diseases Pending 07-May-2018 0000000000

Biotx.ai Executive Team (4)

Name Title Board Seat Contact Info
Jörn Klinger Co-Founder & Chief Executive Officer
Christian Hebenstreit Chief Operating Officer
Charles Ravarani Chief Technology Officer
Marco Schmidt Co-Founder, Managing Director & Chief Scientific Officer
To view Biotx.ai’s complete executive team members history, request access »

Biotx.ai Board Members (1)

Name Representing Role Since
Hussein Kanji Hoxton Ventures Board Member 000 0000
To view Biotx.ai’s complete board members history, request access »

Biotx.ai Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotx.ai Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hoxton Ventures Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
Merck Innovation Center Accelerator/Incubator Minority 000 0000 000000 0
Startupbootcamp Accelerator/Incubator Minority 000 0000 000000 0
Businessplan-Wettbewerb Berlin-Brandenburg Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »